Lefi A, Asmarani D, Dharmadjati B, Suwanto D, Saputra M, Pravitasari V, Anandita F. Efficacy of Optimal Dosage of Lisinopril in Inhibiting Myofibroblast Differentiation for Attenuating Rheumatic Heart Disease Progression (RHD): An In Vitro Study. J Tehran Heart Cent. 2024;.